Personalised medicine strategy 2025-2027

In Denmark, significant progress has already been made in personalised medicine. Thanks to genetic information, we can offer patients more precise and targeted treatments that work better and are more personalised.

This is partly because the government and Danish Regions took the first steps in 2016 with a joint strategy for personalised medicine. Since then, collaboration between the healthcare service, the research community, patient organisations and universities has been strengthened. And in 2019, the Danish National Genome Center was established with support from the Novo Nordisk Foundation. The ambition was clear: to give up to 60,000 patients access to better diagnostics and treatment based on their genetic profile.